Eye Drop Moxifloxacin 0point5percentage bott of 5 ml Ser No 1451, Qty: 15 Bott, (BOQ Item #67)

KuwaitTender notice for Eye Drop Moxifloxacin 0point5percentage bott of 5 ml Ser No 1451, Qty: 15 Bott, (BOQ Item #67). The reference ID of the tender is 117687211 and it is closing on 10 May 2025.

100% Secure Payments

Tender Details

  • Country: India
  • Summary: Eye Drop Moxifloxacin 0point5percentage bott of 5 ml Ser No 1451, Qty: 15 Bott, (BOQ Item #67)
  • KWT Ref No: 117687211
  • Deadline: 10 May 2025
  • Competition: NCB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: GEM/2025/B/6102403
  • Purchaser's Detail :
  • Purchaser : DIRECTOR GENERAL ARMED FORCES MEDICAL SERVICES (DGAFMS)
    Ministry Of Defence
    Department of Defence
    Firozpur 600 15 Acebrophylline 200 Mg Tab
    Email :jpsingh.713a@gov.in
    URL :www.gem.gov.in

  • Description :
  • BOQ Item Description: Eye Drop Moxifloxacin 0point5percentage bott of 5 ml Ser No 1451
  • Documents :
  •  Tender Notice

    Bid_Document_7698084.pdf

    Specification_Document.pdf

    BOQ_Document.csv

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
KuwaitTender Features

KuwaitTender Features

Fresh and verified Tenders from Kuwait. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Kuwait in your email inbox.

  Chat with us